• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number GSX0025A
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Pain (1994); Device Embedded In Tissue or Plaque (3165)
Event Date 04/25/2021
Event Type  Injury  
Manufacturer Narrative
No patient weight was available.The gore® cardioform septal occluder instructions for use state in the section ¿potential device ¿ or procedure-related adverse events¿ adverse events associated with the use of the occluder may include, but are not limited to: device embolization.
 
Event Description
It was reported, the physician implanted a 25mm gore® cardioform septal occluder on (b)(6) 2020.The device was implanted with no issues.On (b)(6) 2021 the patient was feeling pain in the abdomen and went to the hospital.A ct revealed the device had embolized to the distal thoracic aorta, proximal to the ciliac artery.A snare was attempted to remove the device, but it was adhered to the wall of the artery.A terumo aortic endograft was used to pin the occluder against the wall of the artery.The patient was doing well following the procedure.The patient only had a one-month follow-up, showing the device in place.
 
Manufacturer Narrative
B5: updated description with new information.
 
Event Description
It was reported, the physician implanted a 25mm gore® cardioform septal occluder on (b)(6) 2020.The device was implanted with no issues.On (b)(6) 2021 the patient was feeling pain in the abdomen and went to the hospital.A ct revealed the device had embolized to the distal thoracic aorta, proximal to the ciliac artery.A snare was attempted to remove the device, but it was adhered to the wall of the artery.A terumo aortic endograft was used to pin the occluder against the wall of the artery.The patient was doing well following the procedure.After the original implant, the patient was lost to follow-up, so no follow-up imaging was performed.The last images showed the device in place at discharge.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11852381
MDR Text Key255932469
Report Number2017233-2021-02019
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631025
UDI-Public00733132631025
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/04/2021
Device Model NumberGSX0025A
Device Catalogue NumberGSX0025A
Was Device Available for Evaluation? No
Date Manufacturer Received04/25/2021
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age50 YR
-
-